Pipeline Overview

  • Asset / Target
  • Phase I
  • Phase II
  • Phase III
  • NDA

AZD1656 ⁽¹⁾ (HK-4 Glucokinase Activators)

Lupus Nephritis

ANCA Vasculitis

CDT1656

Autoimmune Disorders

AZD5658 (HK-4 Glucokinase Activators)

Autoimmune Disorders

AZD5904 (Myeloperoxidase Inhibitor)

Idiopathic Male Infertility

NOTE:
1.Does not include other potential indications covered under the AZD1656 Cocrystals
2.Further assets may be available to be licensed under existing License Agreement with AstraZeneca